Aim of the work
This study aims to compare the effect of dapagliflozin versus glimepiride on glycemic control, HOMA-IR, and on markers like IRAPe, IL-34, and NT-proBNP, and to establish relationship between these parameters.Primary outcomes: change in the glycemic control and IRAPe.Secondary outcomes: change in the levels of IL-34 and NT-proBNP.